Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.
Kwak L, Ravi P, Armstrong JG, Beckendorf V, Chin JL, D'Amico AV, Dearnaley DP, Di Stasi SM, Gillessen S, Lukka H, Mottet N, Pommier P, Seiferheld W, Sydes MR, Tombal B, Zapatero A, Regan MM, Xie W, Sweeney CJ. Kwak L, et al. Among authors: beckendorf v. J Clin Oncol. 2024 Jun 20;42(18):2132-2138. doi: 10.1200/JCO.23.00762. Epub 2024 Mar 12. J Clin Oncol. 2024. PMID: 38471051
Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.
Pommier P, Chabaud S, Lagrange JL, Richaud P, Lesaunier F, Le Prise E, Wagner JP, Hay MH, Beckendorf V, Suchaud JP, Pabot du Chatelard PM, Bernier V, Voirin N, Perol D, Carrie C. Pommier P, et al. Among authors: beckendorf v. J Clin Oncol. 2007 Dec 1;25(34):5366-73. doi: 10.1200/JCO.2006.10.5171. J Clin Oncol. 2007. PMID: 18048817 Clinical Trial.
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Vaugier L, Morvan C, Pasquier D, Buthaud X, Magné N, Beckendorf V, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Paul J, Blanc-Lapierre A, Supiot S. Vaugier L, et al. Among authors: beckendorf v. Eur Urol. 2025 Jan;87(1):73-76. doi: 10.1016/j.eururo.2024.02.013. Epub 2024 Mar 14. Eur Urol. 2025. PMID: 38490854 Clinical Trial.
Cost of prostate image-guided radiation therapy: results of a randomized trial.
Perrier L, Morelle M, Pommier P, Lagrange JL, Laplanche A, Dudouet P, Supiot S, Chauvet B, Nguyen TD, Crehange G, Beckendorf V, Pene F, Muracciole X, Bachaud JM, Le Prisé E, de Crevoisier R. Perrier L, et al. Among authors: beckendorf v. Radiother Oncol. 2013 Jan;106(1):50-8. doi: 10.1016/j.radonc.2012.11.011. Epub 2013 Jan 17. Radiother Oncol. 2013. PMID: 23333022 Free article. Clinical Trial.
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.
Pommier P, Chabaud S, Lagrange JL, Richaud P, Le Prise E, Wagner JP, Azria D, Beckendorf V, Suchaud JP, Bernier V, Perol D, Carrie C. Pommier P, et al. Among authors: beckendorf v. Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):759-769. doi: 10.1016/j.ijrobp.2016.06.2455. Int J Radiat Oncol Biol Phys. 2016. PMID: 27788949 Clinical Trial.
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
de Crevoisier R, Bayar MA, Pommier P, Muracciole X, Pêne F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud JM, Laplanche A, Supiot S, Chauvet B, Nguyen TD, Bossi A, Créhange G, Lagrange JL. de Crevoisier R, et al. Among authors: beckendorf v. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429. doi: 10.1016/j.ijrobp.2018.07.2006. Epub 2018 Jul 31. Int J Radiat Oncol Biol Phys. 2018. PMID: 30071296 Clinical Trial.
Nomograms to predict late urinary toxicity after prostate cancer radiotherapy.
Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, Bossi A, Le Prisé E, Guerif S, Simon JM, Dubray B, Zhu J, Lagrange JL, Pommier P, Gnep K, Acosta O, De Crevoisier R. Mathieu R, et al. Among authors: beckendorf v. World J Urol. 2014 Jun;32(3):743-51. doi: 10.1007/s00345-013-1146-8. Epub 2013 Aug 29. World J Urol. 2014. PMID: 23990073 Free article.
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.
Beckendorf V, Guerif S, Le Prisé E, Cosset JM, Bougnoux A, Chauvet B, Salem N, Chapet O, Bourdain S, Bachaud JM, Maingon P, Hannoun-Levi JM, Malissard L, Simon JM, Pommier P, Hay M, Dubray B, Lagrange JL, Luporsi E, Bey P. Beckendorf V, et al. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1056-63. doi: 10.1016/j.ijrobp.2010.03.049. Epub 2010 Dec 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 21147514 Clinical Trial.
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity.
Beckendorf V, Guérif S, Le Prisé E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P. Beckendorf V, et al. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1056-65. doi: 10.1016/j.ijrobp.2004.05.033. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519775 Clinical Trial.
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).
Vaugier L, Palpacuer C, Rio E, Goineau A, Pasquier D, Buthaud X, De Laroche G, Beckendorf V, Sargos P, Créhange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Campion L, Supiot S. Vaugier L, et al. Among authors: beckendorf v. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1061-1067. doi: 10.1016/j.ijrobp.2018.12.020. Epub 2018 Dec 14. Int J Radiat Oncol Biol Phys. 2019. PMID: 30557672 Free article. Clinical Trial.
58 results